The Interaction of Mitogen-activated Protein Kinases to Epstein-Barr Virus Activation in Akata Cells

Overview

Journal Virus Genes

Specialties Microbiology
Molecular Biology

Date 1999 May 20

PMID 10334038

Citations 8

Authors

T Satoh

Y Hoshikawa

Y Satoh

T Kurata

T Sairenji

Affiliations

Soon will be listed here.

Abstract

To understand the mechanism by which Epstein-Barr virus (EBV) is activated in Akata cells by cross-linking of surface immunoglobulin, the interaction between mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) and EBV activation was investigated. Immunoblotting using an anti-phosphoMAPK antibody (Ab) revealed that anti-IgG Ab induced rapid phosphorylation of MAPK in the cells. The phosphorylation was inhibited by MAPK/ERK kinase specific inhibitor, PD98059. The expressions of the EBV immediate early BZLF1 mRNA and its protein product ZEBRA, and early antigen were also inhibited by the inhibitor. These results indicate that MAPK is involved in the pathways of EBV activation.

Citing Articles

CD95 Signaling Inhibits B Cell Receptor-Mediated Gammaherpesvirus Replication in Apoptosis-Resistant B Lymphoma Cells.

Tan L, Zhang C, Dematos J, Kuang L, Jung J, Liang X J Virol. 2016; 90(21):9782-9796.

PMID: 27558422 PMC: 5068529. DOI: 10.1128/JVI.00668-16.

EBV microRNA BART 18-5p targets MAP3K2 to facilitate persistence in vivo by inhibiting viral replication in B cells.

Qiu J, Thorley-Lawson D Proc Natl Acad Sci U S A. 2014; 111(30):11157-62.

PMID: 25012295 PMC: 4121837. DOI: 10.1073/pnas.1406136111.

Protein kinase inhibitors that inhibit induction of lytic program and replication of Epstein-Barr virus.

Goswami R, Gershburg S, Satorius A, Gershburg E Antiviral Res. 2012; 96(3):296-304.

PMID: 23058855 PMC: 3513622. DOI: 10.1016/j.antiviral.2012.09.021.

Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk.

Simon K, van der Mei I, Munger K, Ponsonby A, Dickinson J, Dwyer T Neurology. 2010; 74(17):1365-71.

PMID: 20375311 PMC: 2875934. DOI: 10.1212/WNL.0b013e3181dad57e.

Inhibition of Epstein-Barr virus (EBV) reactivation by short interfering RNAs targeting p38 mitogen-activated protein kinase or c-myc in EBV-positive epithelial cells.

Gao X, Wang H, Sairenji T J Virol. 2004; 78(21):11798-806.

PMID: 15479821 PMC: 523256. DOI: 10.1128/JVI.78.21.11798-11806.2004.

References

Daibata M, Humphreys R, Sairenji T . Phosphorylation of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA. Virology. 1992; 188(2):916-20. DOI: 10.1016/0042-6822(92)90553-2. View

Seger R, Ahn N, Posada J, Munar E, Jensen A, Cooper J . Purification and characterization of mitogen-activated protein kinase activator(s) from epidermal growth factor-stimulated A431 cells. J Biol Chem. 1992; 267(20):14373-81. View

Marshall C . Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 1995; 80(2):179-85. DOI: 10.1016/0092-8674(95)90401-8. View

Sairenji T, Hinuma Y . Re-evaluation of a transforming strain of Epstein-Barr virus from the Burkitt lymphoma cell line, Jijoye. Int J Cancer. 1980; 26(3):337-42. DOI: 10.1002/ijc.2910260313. View

Luka J, Kallin B, Klein G . Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology. 1979; 94(1):228-31. DOI: 10.1016/0042-6822(79)90455-0. View

Davis R . The mitogen-activated protein kinase signal transduction pathway. J Biol Chem. 1993; 268(20):14553-6. View

Countryman J, Miller G . Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc Natl Acad Sci U S A. 1985; 82(12):4085-9. PMC: 397939. DOI: 10.1073/pnas.82.12.4085. View

Henle W, Henle G, Zajac B, Pearson G, Waubke R, Scriba M . Differential reactivity of human serums with early antigens induced by Epstein-Barr virus. Science. 1970; 169(3941):188-90. DOI: 10.1126/science.169.3941.188. View

Seger R, KREBS E . The MAPK signaling cascade. FASEB J. 1995; 9(9):726-35. View

10.

Rowe M, Lear A, Croom-Carter D, Davies A, Rickinson A . Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. J Virol. 1992; 66(1):122-31. PMC: 238267. DOI: 10.1128/JVI.66.1.122-131.1992. View

11.

Marais R, Wynne J, Treisman R . The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell. 1993; 73(2):381-93. DOI: 10.1016/0092-8674(93)90237-k. View

12.

Fruehling S, Longnecker R . The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology. 1997; 235(2):241-51. DOI: 10.1006/viro.1997.8690. View

13.

Tordai A, Franklin R, Patel H, Gardner A, Johnson G, Gelfand E . Cross-linking of surface IgM stimulates the Ras/Raf-1/MEK/MAPK cascade in human B lymphocytes. J Biol Chem. 1994; 269(10):7538-43. View

14.

Speck S, Chatila T, Flemington E . Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene. Trends Microbiol. 1997; 5(10):399-405. DOI: 10.1016/S0966-842X(97)01129-3. View

15.

Takagi S, Daibata M, Last T, Humphreys R, Parker D, Sairenji T . Intracellular localization of tyrosine kinase substrates beneath crosslinked surface immunoglobulins in B cells. J Exp Med. 1991; 174(2):381-8. PMC: 2118913. DOI: 10.1084/jem.174.2.381. View

16.

Takada K, Shimizu N, Sakuma S, Ono Y . trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment. J Virol. 1986; 57(3):1016-22. PMC: 252835. DOI: 10.1128/JVI.57.3.1016-1022.1986. View

17.

Gonzalez F, Seth A, Raden D, Bowman D, Fay F, Davis R . Serum-induced translocation of mitogen-activated protein kinase to the cell surface ruffling membrane and the nucleus. J Cell Biol. 1993; 122(5):1089-101. PMC: 2119622. DOI: 10.1083/jcb.122.5.1089. View

18.

Panousis C, Rowe D . Epstein-Barr virus latent membrane protein 2 associates with and is a substrate for mitogen-activated protein kinase. J Virol. 1997; 71(6):4752-60. PMC: 191697. DOI: 10.1128/JVI.71.6.4752-4760.1997. View

19.

Tovey M, Lenoir G . Activation of latent Epstein-Barr virus by antibody to human IgM. Nature. 1978; 276(5685):270-2. DOI: 10.1038/276270a0. View

20.

Anderson N, Maller J, Tonks N, Sturgill T . Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase. Nature. 1990; 343(6259):651-3. DOI: 10.1038/343651a0. View